日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant patients with MPN

罗培干扰素α-2b在患有骨髓增生性肿瘤(MPN)的孕妇中,经胎盘转运和乳汁分泌均极少。

Tashi, Tsewang; Shih, Lee-Yung; Yo, Yi-Te; Sullivan, Amy E; Chueh, Ho-Yen; Kuo, Ming-Chung; Smith, Amanda; Kim, Soo-Jin; Parsegov, Brynn; Reeves, Brandi N; Song, Jihyun; Prchal, Josef T

Biocultural vulnerability of traditional crops in the Indian Trans-Himalaya

印度跨喜马拉雅地区传统作物的生物文化脆弱性

Jaggi, Harman; Anand, Akshata; Solari, Katherine A; Echeverri, Alejandra; Tobge, Rinchen; Tsewang, Tanzin; Suryawanshi, Kulbhushansingh; Tuljapurkar, Shripad

Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients

皮肤肥大细胞增多症:成人和儿童患者的诊断、评估和治疗方法

Madigan, Lauren M; Boggs, Nathan A; Rets, Anton V; Gru, Alejandro A; Tashi, Tsewang; Wada, David A; Florell, Scott R; Carter, Melody C

Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients

更正:皮肤肥大细胞增多症:成人和儿童患者的诊断、评估和治疗方法

Madigan, Lauren M; Boggs, Nathan A; Rets, Anton V; Gru, Alejandro A; Tashi, Tsewang; Wada, David A; Florell, Scott R; Carter, Melody C

Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis

藏族PHD2D4E;C127S变异体在缺氧条件下可抵抗病毒性疾病,但在常氧条件下则通过HIFα:IFN轴易导致感染。

Ghosh, Riya; Joshi, Garima; Shrimali, Nishith M; Bhardwaj, Kanchan; Chorol, Tsewang; Thinlas, Tashi; Koul, Parvaiz A; Prchal, Josef T; Guchhait, Prasenjit

Exploring prokaryotic diversity in permafrost-affected soils of Ladakh's Changthang region and its geochemical drivers

探索拉达克昌塘地区受永久冻土影响土壤中的原核生物多样性及其地球化学驱动因素

Ali, Ahmad; Dolma, Phuntsog; Vishnivetskaya, Tatiana A; Namgail, Tsewang; Dolma, Tundup; Chauhan, Archana

Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms

MPN Asia 2025 亮点:骨髓增生性肿瘤分子发病机制和治疗策略的进展

Bose, Prithviraj; Xiao, Zhijian; Hasselbalch, Hans C; Prchal, Josef T; Duan, Minghui; Yacoub, Abdulraheem; Rampal, Raajit; Kiladjian, Jean-Jacques; Hobbs, Gabriela S; Tashi, Tsewang; Shimoda, Kazuya; Kirito, Keita; Gill, Harinder; Hou, Hsin-An; Lee, Sung-Eun; Huang, Jian; Li, Bing; Qin, Albert; Yu, Lennex Hsueh-Lin; Mascarenhas, John O; Mesa, Ruben A

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial

一项在美国和加拿大开展的多中心研究旨在评估罗培干扰素α-2b-njft治疗原发性血小板增多症患者的疗效、安全性和耐受性:EXCEED-ET试验

Masarova, Lucia; Reeves, Brandi N; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T; Hunter, Anthony M; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj

Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b

应对聚乙二醇干扰素α-2a短缺:将患者过渡到罗培干扰素α-2b的实用指南

Mesa, Ruben; Yacoub, Abdulraheem; Tashi, Tsewang; Chai-Ho, Wanxing; Yoon, Chang Ho; Mascarenhas, John

Results from a US modified Delphi consensus to define disease progression and disease modification in polycythemia Vera

美国改良德尔菲共识法对真性红细胞增多症的疾病进展和疾病改变进行定义的结果

Bose, Prithviraj; Nagler, Emily; Nawaz, Muhammad Sarfraz; Rampal, Raajit K; Tashi, Tsewang; Thota, Swapna; Mascarenhas, John O